Determination of the maturity and functionality of tumor vasculature by MRI: Correlation between BOLD-MRI and DCE-MRI using P792 in experimental fibrosarcoma tumors

Magnetic Resonance in Medicine

Volumn 56, Issue 5, 2006, Pages 1041-1049

  Baudelet, Christine ^a   Cron, Gregory O ^a   Gallez, Bernard ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

BOLD MRI; Carbogen; DCE MRI; Tumor; Vessel maturation; Vessel permeability

Indexed keywords

TUMORS;

BLOOD OXYGEN LEVEL DEPENDENTS; CARBOGEN; DCE-MRI; DYNAMIC CONTRAST ENHANCED MRIS (DCE); POSITIVE CORRELATIONS; QUANTITATIVE PARAMETERS; TUMOR MICROVASCULATURE; VESSEL MATURATION;

MAGNETIC RESONANCE IMAGING;

CARBOGEN; GADOLINIUM; MACROCYCLIC COMPOUND; P 792; UNCLASSIFIED DRUG; VISTAREM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APPARATUS; ARTICLE; BLOOD OXYGEN LEVEL DEPENDENT CONTRAST ENHANCEMENT; BREATHING; CONTRAST ENHANCEMENT; CORRELATION ANALYSIS; DIAGNOSTIC IMAGING; DYNAMIC CONTRAST ENHANCEMENT; FIBROSARCOMA; IMAGE ANALYSIS; IMAGE DISPLAY; IMAGE ENHANCEMENT; IMAGE PROCESSING; INTERMETHOD COMPARISON; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION; PLASMA VOLUME; SIGNAL DETECTION; TUMOR MODEL; TUMOR VASCULARIZATION;

EID: 33750629516     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.21047     Document Type: Article

References (39)

1. Ogawa S, Lee TM. Magnetic resonance imaging of blood vessels at high fields: in vivo and in vitro measurements and image simulation. Magn Reson Med 1990;16:9-18.
2. Baudelet C, Gallez B. Current issues in the utility of blood oxygen level dependent (BOLD) MRI for the assessment of modulations in tumor oxygenation. Curr Med Imaging Rev 2005;1:229-243.
3. Choyke PL, Dwyer AJ, Knopp MV. Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging 2003;17:509-520.
4. Abramovitch R, Itzik A, Harel H, Nagler A, Vlodavsky I, Siegal T. Halofuginone inhibits angiogenesis and growth in implanted metastatic rat brain tumor model-an MRI study. Neoplasia 2004;6:480-489.
5. Hou H, Khan N, O'Hara JA, Grinberg OY, Dunn JF, Abajian MA, Wilmot CM, Makki M, Demidenko E, Lu SY, Steffen RP, Swartz HM. Effect of RSR13, an allosteric hemoglobin modifier, on oxygenation in murine tumors: an in vivo electron paramagnetic resonance oximetry and BOLD-MRI study. Int J Radiat Oncol Biol Phys 2004;59:834-843.
6. Rijpkema M, Kaanders JH, Joosten FB, van der Kogel AJ, Heerschap A. Effects of breathing a hyperoxic hypercapnic gas mixture on blood oxygenation and vascularity of head-and-neck tumors as measured by magnetic resonance imaging. Int J Radiat Oncol Biol Phys 2002;53: 1185-1191.
7. Thomas CD, Chenu E, Walczak C, Plessis MJ, Perin F, Volk A. Relationship between tumour growth rate and carbogen-based functional MRI for a chemically induced HCC in mice. MAGMA 2004;17:271-280.
8. Baudelet C, Gallez B. Cluster analysis of BOLD fMRI time series in tumors to study the heterogeneity of hemodynamic response to treatment. Magn Reson Med 2003;49:985-990.
9. Gross S, Gilead A, Scherz A, Neeman M, Salomon Y. Monitoring photodynamic therapy of solid tumors online by BOLD-contrast MRI. Nat Med 2003;9:1327-1331.
10. Howe FA, Robinson SP, McIntyre DJ, Stubbs M, Griffiths JR. Issues in flow and oxygenation dependent contrast (FLOOD) imaging of tumours. NMR Biomed 2001;14:497-506.
11. Kuperman VY, River JN, Lewis MZ, Lubich LM, Karczmar GS. Changes in T2*-weighted images during hyperoxia differentiate tumors from normal tissue. Magn Reson Med 1995;33:318-325.
12. Jordan BF, Misson P, Demeure R, Baudelet C, Beghein N, Gallez B. Changes in tumor oxygenation/perfusion induced by the no donor, isosorbide dinitrate, in comparison with carbogen: monitoring by EPR and MRI. Int J Radiat Oncol Biol Phys 2000;48:565-570.
13. Baudelet C, Ansiaux R, Jordan BF, Havaux X, Macq B, Gallez B. Physiological noise in murine solid tumours using T2*-weighted gradient-echo imaging: a marker of tumour acute hypoxia? Phys Med Biol 2004;49:3389-3411.
14. Neeman M, Dafni H, Bukhari O, Braun RD, Dewhirst MW. In vivo BOLD contrast MRI mapping of subcutaneous vascular function and maturation: validation by intravital microscopy. Magn Reson Med 2001;45:887-898.
15. Gilead A, Meir G, Neeman M. The role of angiogenesis, vascular maturation, regression and stroma infiltration in dormancy and growth of implanted MLS ovarian carcinoma spheroids. Int J Cancer 2004;108: 524-531.
16. Gilad AA, Israely T, Dafni H, Meir G, Cohen B, Neeman M. Functional and molecular mapping of uncoupling between vascular permeability and loss of vascular maturation in ovarian carcinoma xenografts: The role of stroma cells in tumor angiogenesis. Int J Cancer 2005;117:202-211.
17. Abramovitch R, Dafni H, Smouha E, Benjamin LE, Neeman M. In vivo prediction of vascular susceptibility to vascular susceptibility endothelial growth factor withdrawal: magnetic resonance imaging of C6 rat glioma in nude mice. Cancer Res 1999;59:5012-5016.
18. Robinson SP, Rijken PF, Howe FA, McSheehy PM, van der Sanden BP, Heerschap A, Stubbs M, van. der Kogel AJ, Griffiths, JR. Tumor vascular architecture and function evaluated by non-invasive susceptibility MRI methods and immunohistochemistry. J Magn Reson Imaging 2003;17: 445-454.
19. Robinson SP, Collingridge DR, Howe FA, Rodrigues LM, Chaplin DJ, Griffiths JR. Tumour response to hypercapnia and hyperoxia monitored by FLOOD magnetic resonance imaging. NMR Biomed 1999;12:98-106.
20. Padhani AR, Husband JE. Dynamic contrast-enhanced MRI studies in oncology with an emphasis on quantification, validation and human studies. Clin Radiol 2001;56:607-620.
21. Padhani AR. Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions. J Magn Reson Imaging 2002;16: 407-422.
22. Rijpkema M, Schuuring J, Bernsen PL, Bernsen HJ, Kaanders JH, van der Kogel AJ, Heerschap A. BOLD-MRI response to hypercapnic hyperoxia in patients with meningiomas: correlation with gadolinium-DTPA uptake rate. Magn Reson Imaging 2004;22:761-767.
23. Jiang L, Zhao D, Constantinescu A, Mason RP. Comparison of BOLD contrast and Gd-DTPA dynamic contrast-enhanced imaging in rat prostate tumor. Magn Reson Med 2004;51:953-960.
24. Peller M, Weissfloch L, Stehling MK, Weber J, Bruening R, Senekowitsch-Schmidtke R, Molls M, Reiser M. Oxygen-induced MR signal changes in murine tumors. Magn Reson Imaging 1998;16:799-809.
25. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, Larsson HB, Lee TY, Mayr NA, Parker GJ, Port RE, Taylor J, Weisskoff RM. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999;10:223-232.
26. Rodrigues LM, Howe FA, Griffiths JR, Robinson SP. Tumor R2* is a prognostic indicator of acute radiotherapeutic response in rodent tumors. J Magn Reson Imaging 2004;19:482-488.
27. Baudelet C, Cron GO, Ansiaux R, Crokart N, Dewever J, Feron O, Gallez B. The role of vessel maturation and vessel functionality in spontaneous fluctuations of T(2)*-weighted GRE signal within tumors. NMR Biomed 2006;19:69-76.
28. Fan X, Medved M, River JN, Zamora M, Corot C, Robert P, Bourrinet P, Lipton M, Culp RM, Karczmar GS. New model for analysis of dynamic contrast-enhanced MRI data distinguishes metastatic from nonmetastatic transplanted rodent prostate tumors. Magn Reson Med 2004;51: 487-494.
29. Friston KJ, Holmes AP, Poline JB, Grasby PJ, Williams SC, Frackowiak RS, Turner R. Analysis of fMRI time-series revisited. Neuroimage 1995; 2:45-53.
30. Dvorak HF. Angiogenesis: update 2005. J Thromb Haemost 2005;3: 1835-1842.
31. Turetschek K, Floyd E, Shames DM, Roberts TP, Preda A, Novikov V, Corot C, Carter WO, Brasch RC. Assessment of a rapid clearance blood pool MR contrast medium (P792) for assays of microvascular characteristics in experimental breast tumors with correlations to histopathology. Magn Reson Med 2001;45:880-886.
32. Baudelet C, Gallez B. How does blood oxygen level-dependent (BOLD) contrast correlate with oxygen partial pressure (pO2) inside tumors? Magn Reson Med 2002;48:980-986.
33. Fan X, River JN, Zamora M, al Hallaq HA, Karczmar GS. Effect of carbogen on tumor oxygenation: combined fluorine-19 and proton MRI measurements. Int J Radiat Oncol Biol Phys 2002;54:1202-1209.
34. al Hallaq HA, Fan X, Zamora M, River JN, Moulder JE, Karczmar GS. Spectrally inhomogeneous BOLD contrast changes detected in rodent tumors with high spectral and spatial resolution MRI. NMR Biomed 2002;15:28-36.
35. Foxley S, Yang C, Fan X, Zamora M, Panti R, River JN, Karczmar GS. The use of high spatial and spectral resolution Fourier component difference images to detect BOLD response in mouse tumors [Abstract]. In: Proceedings of the 13th Annual Meeting of ISMRM, Miami Beach, FL, USA, 2005. p 2108.
36. Ruehm SG, Christina H, Violas X, Corot C, Debatin JF. MR angiography with a new rapid-clearance blood pool agent: Initial experience in rabbits. Magn Reson Med 2002;48:844-851.
37. Dewhirst MW. Concepts of oxygen transport at the microcirculatory level. Semin Radiat Oncol 1998;8:143-150.
38. Griffiths JR, Taylor NJ, Howe FA, Saunders MI, Robinson SP, Hoskin PJ, Powell ME, Thoumine M, Caine LA, Baddeley H. The response of human tumors to carbogen breathing, monitored by gradient-recalled echo magnetic resonance imaging. Int J Radiat Oncol Biol Phys 1997; 39:697-701.
39. Zlotecki RA, Baxter LT, Boucher Y, Jain RK. Pharmacologic modification of tumor blood flow and interstitial fluid pressure in a human tumor xenograft: network analysis and mechanistic interpretation. Microvasc Res 1995;50:429-443.